MedPath

Hemoglobinopathy Nursing Program and Pediatric Nursing Students

Not Applicable
Completed
Conditions
Hemoglobinopathies
Sickle Cell Disease
Nurse's Role
Thalassemia
Registration Number
NCT05389891
Lead Sponsor
Beni-Suef University
Brief Summary

Hemoglobinopathies are the most common life threatening, monogenic disorders in the world. The most common causes of hemoglobinopathies are sickle cell disease and thalassemia. Aim: This study aimed to evaluate the effect of a hemoglobinopathy nursing program on pediatric nursing students' performance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  • pediatric nursing students registered for the academic year 2016/2017
Exclusion Criteria
  • Any student had personal or family history of hemoglobinopathies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pediatric nursing students' Attitude10 weeks

Pediatric nursing students' Attitude Scale

- nine (9) questions. A five-point Likert scale by give a score of (four) for Strongly Agree, (three) for Agree, (two) for Undecided, (one) for Disagree and (zero) for Strongly Disagree. The total score ranged from (0-36 mark).

Pediatric nursing students' awareness10 weeks

Measure Students' awareness through:

01. Personal Data and PNSs' Awareness Questionnaire

-sixty (60) questions. A score of (one) for correct answers, and (zero) for the wrong answers. The total scores ranged from (0-60 mark).

Pediatric nursing students' Practice10 weeks

Observational Checklists - forty (40) items. A score of (two) for completely done, (one) for incompletely done and (zero) for not done. The total score ranged from (0-80 mark), scores less than 60% were considered incompetent practice.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Benha University

🇪🇬

Banhā, Other, Egypt

Benha University
🇪🇬Banhā, Other, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.